Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 11:17:1235-1248.
doi: 10.2147/DMSO.S456173. eCollection 2024.

An Update on the Role and Potential Molecules in Relation to Ruminococcus gnavus in Inflammatory Bowel Disease, Obesity and Diabetes Mellitus

Jinni Hong  1   2 , Tingting Fu  1   2 , Weizhen Liu  1   2 , Yu Du  1   2 , Junmin Bu  1   2 , Guojian Wei  1   2 , Miao Yu  1   2 , Yanshan Lin  1   2 , Cunyun Min  1   2 , Datao Lin  3
Affiliations
Review

An Update on the Role and Potential Molecules in Relation to Ruminococcus gnavus in Inflammatory Bowel Disease, Obesity and Diabetes Mellitus

Jinni Hong et al. Diabetes Metab Syndr Obes. .

Abstract

Ruminococcus gnavus (R. gnavus) is a gram-positive anaerobe commonly resides in the human gut microbiota. The advent of metagenomics has linked R. gnavus with various diseases, including inflammatory bowel disease (IBD), obesity, and diabetes mellitus (DM), which has become a growing area of investigation. The initial focus of research primarily centered on assessing the abundance of R. gnavus and its potential association with disease presentation, taking into account variations in sample size, sequencing and analysis methods. However, recent investigations have shifted towards elucidating the underlying mechanistic pathways through which R. gnavus may contribute to disease manifestation. In this comprehensive review, we aim to provide an updated synthesis of the current literature on R. gnavus in the context of IBD, obesity, and DM. We critically analyze relevant studies and summarize the potential molecular mediators implicated in the association between R. gnavus and these diseases. Across numerous studies, various molecules such as methylation-controlled J (MCJ), glucopolysaccharides, ursodeoxycholic acid (UDCA), interleukin(IL)-10, IL-17, and capric acid have been proposed as potential contributors to the link between R. gnavus and IBD. Similarly, in the realm of obesity, molecules such as hydrogen peroxide, butyrate, and UDCA have been suggested as potential mediators, while glycine ursodeoxycholic acid (GUDCA) has been implicated in the connection between R. gnavus and DM. Furthermore, it is imperative to emphasize the necessity for additional studies to evaluate the potential efficacy of targeting pathways associated with R. gnavus as a viable strategy for managing these diseases. These findings have significantly expanded our understanding of the functional role of R. gnavus in the context of IBD, obesity, and DM. This review aims to offer updated insights into the role and potential mechanisms of R. gnavus, as well as potential strategies for the treatment of these diseases.

Keywords: Ruminococcus gnavus; diabetes mellitus; inflammatory bowel disease; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests in this work.

Figures

None
Graphical abstract
Figure 1
Figure 1
Molecules in relation to R. gnavus in IBD.
Figure 2
Figure 2
Molecules in relation to R. gnavus in obesity and DM.
See this image and copyright information in PMC

References

    1. Mohamed AA, Al-Ramadi BK, Fernandez-Cabezudo MJ. Interplay between Microbiota and gammadelta T Cells: insights into Immune Homeostasis and Neuro-Immune Interactions. Int J Mol Sci. 2024;25(3):1747. doi:10.3390/ijms25031747 - DOI - PMC - PubMed
    1. He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 2017;7(1):54. doi:10.1186/s13578-017-0183-1 - DOI - PMC - PubMed
    1. Gravina AG, Pellegrino R, Auletta S, et al. Hericium erinaceus, a medicinal fungus with a centuries-old history: evidence in gastrointestinal diseases. World J Gastroenterol. 2023;29(20):3048–3065. doi:10.3748/wjg.v29.i20.3048 - DOI - PMC - PubMed
    1. Gravina AG, Pellegrino R, Palladino G, et al. Hericium erinaceus, in combination with natural flavonoid/alkaloid and B(3)/B(8) vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study. Front Immunol. 2023;14:1215329. doi:10.3389/fimmu.2023.1215329 - DOI - PMC - PubMed
    1. Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535(7610):75–84. doi:10.1038/nature18848 - DOI - PubMed